Domain registrar and web services company GoDaddy (NYSE:GDDY) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $1.27 billion. On the other hand, next quarter’s revenue guidance of $1.26 billion was less impressive, coming in 1.4% below analysts’ estimates. Its GAAP profit of $1.80 per share was 14% above analysts’ consensus estimates.
Home automation and security solutions provider Resideo Technologies (NYSE:REZI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 2% year on year to $1.90 billion. On top of that, next quarter’s revenue guidance ($1.88 billion at the midpoint) was surprisingly good and 4.6% above what analysts were expecting. Its non-GAAP profit of $0.50 per share was 4.5% below analysts’ consensus estimates.
Biopharma company Corcept Therapeutics (NASDAQ:CORT) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 11.1% year on year to $202.1 million. Its GAAP profit of $0.20 per share was 26.3% below analysts’ consensus estimates.
Medical device company Globus Medical (NYSE:GMED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 25.7% year on year to $826.4 million. The company’s full-year revenue guidance of $3.2 billion at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $1.28 per share was 11% above analysts’ consensus estimates.
Composite decking and railing products manufacturer Trex Company (NYSE:TREX) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 3.9% year on year to $161.1 million. The company’s full-year revenue guidance of $1.21 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $0.04 per share was significantly above analysts’ consensus estimates.
Healthcare solutions company Evolent Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 27.5% year on year to $468.7 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 4.9% above analysts’ estimates. Its non-GAAP profit of $0.08 per share was 62.7% above analysts’ consensus estimates.
Medical device company Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue in Q4 CY2025, with sales up 10.9% year on year to $393.9 million. The company’s full-year revenue guidance of $1.62 billion at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $0.93 per share was 2.5% below analysts’ consensus estimates.
Traffic solutions company Verra Mobility (NYSE:VRRM) announced better-than-expected revenue in Q4 CY2025, with sales up 16.4% year on year to $257.9 million. The company expects the full year’s revenue to be around $1.03 billion, close to analysts’ estimates. Its non-GAAP profit of $0.30 per share was 4.1% below analysts’ consensus estimates.
Professional services firm Huron Consulting Group (NASDAQ:HURN) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 10.7% year on year to $442 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.82 billion at the midpoint. Its non-GAAP profit of $2.17 per share was 11.3% above analysts’ consensus estimates.
MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and reconsider nuclear expansion, attention is turning to future uranium supply and how quickly projects like Rook I can begin production.
Infrastructure equipment supplier SPX Technologies (NYSE:SPXC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 19.4% year on year to $637.3 million. The company’s full-year revenue guidance of $2.57 billion at the midpoint came in 3.8% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 0.7% above analysts’ consensus estimates.
Real estate technology company eXp World (NASDAQ:EXPI) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 8.5% year on year to $1.19 billion. Its GAAP loss of $0.08 per share was significantly below analysts’ consensus estimates.
Given its solid fundamentals, strong balance sheet, steady cash flow generation, and promising growth outlook, Whitecap Resources appears well-positioned to appeal to income-focused investors seeking both stability and long-term return potential.
Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 3.4% year on year to $148.9 million. Its non-GAAP profit of $2.44 per share was 9.2% above analysts’ consensus estimates.
Aerospace and defense technology solutions provider Astronics Corporation (NASDAQ:ATRO) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 15.1% year on year to $240.1 million. On the other hand, next quarter’s revenue guidance of $225 million was less impressive, coming in 3.3% below analysts’ estimates. Its non-GAAP profit of $0.75 per share was 25% above analysts’ consensus estimates.
Self defense company AXON (NASDAQ:AXON) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 38.5% year on year to $796.7 million. The company’s full-year revenue guidance of $6 billion at the midpoint came in 74.4% above analysts’ estimates. Its non-GAAP profit of $2.15 per share was 34.5% above analysts’ consensus estimates.
Solar panel manufacturer First Solar (NASDAQ:FSLR) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.1% year on year to $1.68 billion. On the other hand, the company’s full-year revenue guidance of $5.05 billion at the midpoint came in 17.4% below analysts’ estimates. Its GAAP profit of $4.84 per share was 6.3% below analysts’ consensus estimates.
Personal computing and printing company HP (NYSE:HPQ) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.9% year on year to $14.44 billion. Its non-GAAP profit of $0.81 per share was 5.3% above analysts’ consensus estimates.
Mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 20.9% year on year to $275 million. Its GAAP profit of $0.04 per share was $0.01 above analysts’ consensus estimates.
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.77%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.09%. March E-mini S&P futures (ESH26 ) rose +0.76%, and Ma...
Online fashion retailer Revolve (NASDAQ:RVLV) announced better-than-expected revenue in Q4 CY2025, with sales up 10.4% year on year to $324.4 million. Its GAAP profit of $0.26 per share was 57.8% above analysts’ consensus estimates.
Workday Inc. reported revenues of $2.53 billion, an increase of 14.5% from the same period last year, and marginally above Wall Street estimates of $2.52 billion, as per data from Fiscal.ai.
